Candida auris, an emerging fungal pathogen resistant to many antimicrobial agents, continues to threaten US public health. Researchers at bioMérieux Inc. conducted a retrospective analysis of blood cultures positive for C. auris and found an upsurge in detection of this pathogenic yeast between 2021 and 2023.
